Infertility Is a Couple's Diagnosis: Why Both Partners Need Evaluation

When a couple has been trying to conceive for twelve months without success — or six months if the female partner is over 35 — the instinct in too many primary care offices is still to refer the woman first and "see what comes back." That sequence costs couples months they often do not have, and it ignores one of the most consistently reported findings in reproductive medicine: infertility is, statistically, a shared diagnosis.

According to the American Society for Reproductive Medicine (ASRM), in approximately one-third of infertility cases a male factor is the sole contributor, in another third a female factor is the sole contributor, and in the remaining third there are contributions from both partners or the cause is unexplained. Put another way: in roughly 50% of couples struggling to conceive, the male partner has a finding that is either causing or contributing to the problem. Evaluating only one partner, then, has a coin-flip chance of missing the answer entirely.

What "Couple's Diagnosis" Actually Means in Practice

The phrase is more than rhetorical. It means the workup should start with both partners at the same time, in parallel — not sequentially. A semen analysis is inexpensive (often $75–$200 in Canada and the US when not covered), non-invasive, and can be completed in under two weeks. A female partner's baseline workup — cycle day 2 or 3 bloodwork, anti-Müllerian hormone (AMH), a pelvic ultrasound for antral follicle count, and a hysterosalpingogram (HSG) to assess tubal patency — typically takes one full menstrual cycle to complete.

If a clinic only evaluates the female partner and then, three months later, decides to "also check his side," the couple has lost a quarter of a year. For a 38-year-old woman whose ovarian reserve is declining roughly 3–5% per year, that delay has real consequences for cumulative live birth rates.

The Male Workup: What a Real Evaluation Looks Like

A meaningful male evaluation goes beyond a single semen sample. ASRM and the American Urological Association (AUA), in their 2024 joint best practice statement, recommend the following baseline:

• A reproductive history and physical exam. This catches varicoceles (palpable in roughly 15% of the general male population and up to 40% of men presenting with infertility), undescended testes, prior infections, and exposures.
• At least one semen analysis using WHO 6th edition reference values. Lower reference limits include sperm concentration of 16 million/mL, total motility of 42%, progressive motility of 30%, and normal morphology of 4% using strict Kruger criteria. A single abnormal result should always be repeated 2–3 months later, because spermatogenesis takes about 74 days and a single sample can be skewed by a fever, a recent illness, or even a hot tub.
• Hormonal evaluation when count is low or symptoms suggest it: FSH, LH, total testosterone, and sometimes prolactin and estradiol.
• Genetic testing (karyotype, Y-chromosome microdeletion, CFTR) when sperm concentration is under 5 million/mL or when azoospermia is found.
• Specialized testing — including sperm DNA fragmentation analysis — in cases of recurrent pregnancy loss, repeated IVF failure, or unexplained infertility. Elevated DNA fragmentation (often defined as >30%) is associated with lower natural conception rates and higher miscarriage risk.

If something abnormal turns up, the next referral should be to a reproductive urologist — not a general urologist. The distinction matters: reproductive urologists are fellowship-trained in male infertility and are the specialists who perform microsurgical varicocelectomy, vasectomy reversals, and surgical sperm retrieval procedures such as micro-TESE (microsurgical testicular sperm extraction), which can yield sperm even in many men with non-obstructive azoospermia.

Common Male Factor Causes — and What Can Be Done

The most frequently identified causes in male factor infertility include:

1. Varicocele — dilated veins in the scrotum that raise testicular temperature and impair sperm production. Microsurgical repair has been shown to improve semen parameters in a majority of properly selected men.
2. Low sperm count (oligozoospermia) or complete absence of sperm in the ejaculate (azoospermia). Azoospermia affects roughly 1% of all men and up to 10–15% of infertile men.
3. Poor motility (asthenozoospermia) — often related to varicocele, infection, anti-sperm antibodies, or oxidative stress.
4. Abnormal morphology (teratozoospermia) — important but less independently predictive than count and motility.
5. High DNA fragmentation — often missed on a standard semen analysis and worth pursuing in unexplained infertility or recurrent loss.
6. Hormonal causes — including hypogonadotropic hypogonadism, which is one of the few truly treatable causes of azoospermia.
7. Obstructive causes — prior vasectomy, congenital absence of the vas deferens (often linked to CFTR mutations), or post-infectious scarring.

Use the Fertility Link Navigator to see which clinics in your province or state have on-site andrology labs and a reproductive urologist on staff — two things you genuinely want under one roof if a male factor shows up.

Lifestyle Factors: What the Evidence Actually Supports

Patients are often handed a long list of lifestyle "rules" with very little distinction between things that matter and things that don't. Based on the evidence the ASRM and Canadian Urological Association cite as well-supported:

• Smoking (including cannabis) is consistently associated with reduced sperm concentration, motility, and morphology, and with elevated DNA fragmentation. Cessation is one of the highest-yield interventions.
• Body mass index outside the normal range — particularly a BMI over 30 — is associated with lower testosterone, altered estradiol, and reduced sperm quality. Even a 5–10% reduction in body weight can improve parameters.
• Heat exposure — saunas, hot tubs, laptops on laps, prolonged tight clothing, and febrile illness — temporarily impairs spermatogenesis. Effects typically reverse within one full sperm cycle (about 74 days).
• Alcohol in heavy or daily amounts is associated with reduced semen quality; moderate intake has weaker evidence.
• Anabolic steroids and exogenous testosterone suppress the hypothalamic-pituitary-gonadal axis and can cause azoospermia. This is critically important: a man on testosterone replacement who wants to conceive must usually stop and switch to alternatives such as hCG or clomiphene under specialist care.
• Certain medications — including some SSRIs, alpha-blockers, finasteride, sulfasalazine, and chemotherapy agents — can affect sperm production or function. Always disclose every prescription and supplement.

The lifestyle changes worth making are not glamorous, and supplements marketed aggressively to men trying to conceive (proprietary antioxidant blends, "fertility boosters") have a much weaker evidence base than their marketing suggests. A 2024 Cochrane review found low to moderate certainty evidence for antioxidants improving live birth rates, but methodological quality across studies was poor.

Why Sequential Testing Fails Couples

A common pattern: the female partner gets her workup, comes back normal, is told to "try a few more cycles," and only at the next visit is the male asked for a semen analysis. Six months have now passed. If that analysis comes back showing severe oligozoospermia, the couple is now looking at IVF with ICSI — not because the diagnosis was complicated, but because no one ordered a $150 test in month one.

Simultaneous evaluation does three things sequential testing cannot:

• It identifies couples who need IVF/ICSI immediately rather than wasting cycles on timed intercourse or IUI.
• It surfaces treatable conditions (varicocele, hormonal issues, vasectomy reversal candidates) that, if addressed, may allow natural conception or less invasive treatment.
• It validates both partners. Infertility is often emotionally framed as a woman's problem; a workup that starts with both partners signals from day one that this is a shared medical situation.

The ASRM 2024 practice committee opinion on the evaluation of the infertile male is unambiguous on this point: evaluation of the male should occur concurrently with that of the female partner, not after.

What to Ask Your Family Doctor or GP

If you have been trying to conceive for the recommended interval (12 months under 35, 6 months at 35 or older, sooner with known risk factors), ask specifically:

• "Can you order a semen analysis at the same time you refer my partner for fertility workup?"
• "If anything comes back abnormal, can the referral go to a reproductive endocrinologist and a reproductive urologist?"
• "Is there a clinic in our region with an on-site andrology lab so we don't lose sample quality in transit?"

Andrology lab proximity matters. Sperm samples ideally need to be analyzed within one hour of collection at body temperature; long transit times can degrade motility readings and produce misleading results.

Get Your Personalized Roadmap

Knowing the workup matters. Finding a clinic that actually offers all of it under one roof — reproductive endocrinology, an accredited andrology lab, and access to a reproductive urologist — is the harder part, and it varies enormously by city and province.

Get your personalized roadmap — register at The Fertility Link to see your scored clinic matches based on your specific situation, including which clinics in your area offer integrated male and female evaluation, sperm DNA fragmentation testing, and surgical sperm retrieval. You can also explore our clinic directory and province-specific guides to compare funding, wait times, and on-site services before you book a single appointment.